The results indicated that the methanol extract of Hypericum perforatum demonstrated a potent inhibition of both acetylcholinesterase and butyrylcholinesterase, suggesting that it could potentially be used as a therapeutic agent in neurodegenerative conditions such as Alzheimer’s disease. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.